As enacted

Contents

National Medicines Regulatory Authority Act 2015 · As enacted · Part II · Appointment of Chief Executive Officer and Staff of the Authority

15. Appointment of the Chief Executive Officer of the Authority

Official English translation. Where it differs from the Sinhala or Tamil text, the Act itself says which text prevails.

(1)

The Authority shall in consultation with the

Minister, appoint to the Staff of the Authority a Chief

Executive Officer (hereinafter referred to as the “CEO”) from among persons who hold a postgraduate degree from a recognized University in Medicine, Pharmacology,

Pharmacy or any other related discipline with at least five years management experience at senior executive level.

(2)

The CEO shall subject to the general directions and supervision of the Authority -

(a)

be charged with the administration of the affairs of the Authority including the administration and control of the staff;

(b)

be responsible for the execution of all decisions of the Authority;

(c)

carry out all such functions as may be assigned to him by the Authority; and

(d)

function as the Secretary to the Authority.

(3)

The Authority may in consultation with the Minister remove the CEO from office -

(a)

if he becomes permanently incapable of performing his duties;

(b)

if he has done any act which, is of a fraudulent or illegal character or is prejudicial to the interests of the Authority; or

(c)

has failed to comply with any directions issued by the Authority.

(4)

The term of office of the CEO shall be for a period of three years from the date of appointment and shall be eligible for re-appointment.

(5)

The office of the CEO shall become vacant upon the death, removal from office under subsection (3) or resignation by letter in that behalf addressed to the Minister by the holder of that office.

(6)

If any vacancy occurs in the office of the CEO, the

Authority may appoint any other suitable officer of the

Authority to perform the duties of the CEO until an appointment is made under subsection (1).

Read on from s 16

Part III